Ark Biosciences, a bio-pharmaceutical startup company headquartered in Zhangjiang, Pudong, Shanghai recently announced that the new anti-RSV drug it developed has undergone phase II clinical trials in many countries and regions.
US multinational company Dow Chemical Co is seeking to expand its presence in China by striking a cooperation deal with 1688.com, an online wholesale platform launched by China's e-commerce giant Alibaba, on Aug 8.
Shanghai's ports of entry began granting a new 24-hour visa-free transit and an emergency temporary entry permit as of Aug 1.
Shanghai has been working on improving its intellectual property protection by reducing patent approval time and enhancing judicial protection.
The Shanghai government introduced a guideline on July 24 to improve the quality of its health care service industry and develop itself into the epicenter for medical innovation in Asia.
Zhangjiang National Innovation Demonstration Zone in Shanghai is widely seen as an exemplar for building a science and innovation center with global influence.
Zhangjiang National Innovation Demonstration Zone has played a prominent role in promoting the development of stem cell therapy technologies over the past few years in China.
With its forward-looking layout and innovation-driven ethos, Zhangjiang National Innovation Demonstration Zone in Shanghai has fully committed itself to consolidating its leading position in the cutting-edge development of quantum communications.